NFKB1 and Arthritis: Pro-inflammatory cytokines, pro-inflammatory enzymes, and MMPs are regulated by the NF-κB signaling pathway, and the inhibition of NF-κB activation has been reported to be a potential target in the treatment of arthritis [39].